Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Defra permits licensed use of bluetongue vaccines
Movement restrictions will still apply to vaccinated animals.
The unauthorised vaccines are expected to lessen symptoms.

The use of three unauthorised vaccines for bluetongue virus serotype 3 (BTV-3) will be permitted in the UK subject to licence, the Department for Environment, Food and Rural Affairs (Defra) has announced.

The three vaccines permitted for use are Bultavo-3, BLUEVAC-3, and Syvazul BTV3. All three have been used in other European countries.

The vaccines are not expected to prevent animals from being infected by the virus or spreading it to other animals. However, the vaccines claim to reduce or prevent the clinic signs of bluetongue.

Because vaccinated animals will still be infectious, movement and trade restrictions will still apply to them.

It is expected that licences will become available in the coming days. The vaccines will have to be prescribed by a veterinary surgeon.

New cases of BTV-3 continue to be confirmed in England. In addition to recent cases in Norfolk and Suffolk, a case was confirmed at premises near Withersea in the East Riding of Yorkshire on 4 September. A 20km temporary control zone has been put in place and the affected animal will be culled.

A restricted zone is currently in place Essex, Suffolk, and Norfolk. A specific licence is required to move animals outside the zone and farmers are urged to only move animals within the zone when it’s absolutely essential.

Bluetongue is a notifiable disease. Suspected cases must be reported on 03000 200 301 in England or 03003 038 268 in Wales. In Scotland, suspected cases should be reported to the local field services office.

More information on the vaccine permits is available here. Further information on the restrictions can be found here.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.